Evidence map›Paper›PMID 41853333›Full record

ArticleFrontiers in microbiomes2023

Faecal markers of intestinal inflammation in slum infants following yogurt intervention: A pilot randomized controlled trial in Bangladesh.

Kaniz Jannat, Md Abdul Kader, Sarker Masud Parvez, Russell Thomson, Mahbubur Rahman, Mamun Kabir, Kingsley Agho, Rashidul Haque, Dafna Merom

Abstract read
In one paragraph

Article in Frontiers in microbiomes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kaniz JannatSchool of Health Sciences/Centre for Research in Mathematics and Data Science, Western Sydney University, Sydney, NSW, Australia.
Md Abdul KaderEnvironmental Intervention Unit/Emerging Infections and Parasitology Laboratory, Infectious Disease Division, icddrb, Dhaka, Bangladesh.
Sarker Masud ParvezEnvironmental Intervention Unit/Emerging Infections and Parasitology Laboratory, Infectious Disease Division, icddrb, Dhaka, Bangladesh.
Russell ThomsonSchool of Health Sciences/Centre for Research in Mathematics and Data Science, Western Sydney University, Sydney, NSW, Australia.
Mahbubur RahmanEnvironmental Intervention Unit/Emerging Infections and Parasitology Laboratory, Infectious Disease Division, icddrb, Dhaka, Bangladesh.
Mamun KabirEnvironmental Intervention Unit/Emerging Infections and Parasitology Laboratory, Infectious Disease Division, icddrb, Dhaka, Bangladesh.
Kingsley AghoSchool of Health Sciences/Centre for Research in Mathematics and Data Science, Western Sydney University, Sydney, NSW, Australia.
Rashidul HaqueEnvironmental Intervention Unit/Emerging Infections and Parasitology Laboratory, Infectious Disease Division, icddrb, Dhaka, Bangladesh.
Dafna MeromSchool of Health Sciences/Centre for Research in Mathematics and Data Science, Western Sydney University, Sydney, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: We evaluated the effects of yogurt supplementation and nutrition education to low educated mothers on infant-gut health at an early age. Methods: We designed a three-arm pilot randomized controlled trial with 162 infants aged 5-6 months and at risk of stunting (LAZ ≤-1 SD and >-2 SD at enrollment) living in slum areas in Dhaka, Bangladesh. Eligible children were randomized to receive, 1) nutrition education, 2) yogurt supplementation plus nutrition education or 3) usual care. Three faecal inflammatory biomarkers alpha-1 antitrypsin (AAT), myeloperoxidase (MPO), and neopterin (NEO) were measured before and after three months of yogurt feeding. Results: At the end of three months, there were no significant differences in the biomarker concentrations between the yogurt plus group and control. Compared to control, the adjusted mean faecal NEO concentration decreased by 21% (NEO: RR 0.79, 95% CI: 0.60, 1.04) and the adjusted mean faecal AAT concentration decreased by 8% (AAT: RR 0.92, 95% CI: 0.69, 1.22); whereas, the adjusted mean faecal MPO concentration increased by 14% (MPO: RR 1.14, 95% CI: 0.62, 2.09). Such changes were not apparent in the education only group. Discussion: After a three-month trial of daily yogurt feeding to children at risk of stunting and infant feeding education to their mothers, reduction in one inflammatory biomarker reached close to statistical significance, but not all of the measured biomarkers. The study did not finish its endline measurements at 6-month as designed due to COVID 19 pandemic. This has greatly impacted the interpretation of the results as we could not establish a decreasing trend in biomarker concentration with continued yogurt feeding.

Indexed as

gut healthInfant growthLMIC (low and middle-income countries)randomized controlled clinical trial (RCT)yogurt

Identifiers

PMID41853333
PMCPMC12993563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.